Navigation Links
Trovagene to Present at Leerink Swan Global Healthcare Conference
Date:2/6/2013

nd European patent applications and issued patents that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing. In addition, it owns worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myelogenous leukemia (AML) and mutations in the SF3B1 gene, which have been shown to be associated with chemotherapy response in chronic lymphocytic leukemia (CLL) patients, as well as other hematologic malignancies.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others. These forward-looking statements are based on Trovagene's current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our ability to continue as a going concern; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or third party payer reimbursement; limited sales and marketing efforts and dependence upon third parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any medical diagnostic tests under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that future clinical trials discussed in this press release will be completed or successful or that any product will receive regulatory approval for any indication or prove to be commercially successful. Trovagene does not undertake an obligation to update or revise any forward-looking statement.  Investors should read
'/>"/>

SOURCE Trovagene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Trovagene to be Added to Russell Microcap Index
2. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
3. Trovagene and Strand Life Sciences Plan Collaboration to Validate and Offer Urine-Based HPV Screening Test in India and South Asia
4. TrovaGene Acquires CLIA - Certified Laboratory
5. TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
6. Probiotic Action Representative Fernando Perez Shares Tips for Parents with Teens Suffering from Acne and Depression
7. Oracle’s Value Chain Summit San Francisco: Track Sponsor NexInfo presents more industry specific solutions
8. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
9. Fertility Associates of Memphis, World-Renowned Expert in Infertility, Presents Findings to European Conference
10. Salimetrics to Present Workshop on the Integration of Salivary Analytes into Scientific Studies at the Society for Research in Child Development (SRCD) Preconference
11. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... in Syracuse University,s College of Arts and Sciences ... synthesis of stainless nanoparticles. , Mathew M. Maye, ... three-year, $360,000 grant from the National Science Foundation ... metal stainless alloy nanostructures, the results of which ... lithium-ion batteries. , Maye,s approach is ...
(Date:7/20/2014)... When nuclear fuel gets recycled, the process releases radioactive ... contaminates basements with the related gas radon. A new ... research appearing July 20 in Nature Materials ... in but not out. , The CC3 material ... elements from nuclear fuel or air in buildings and ...
(Date:7/18/2014)... Illinois at Urbana-Champaign have demonstrated that an array ... used like traditional photographic film to record light ... wavelength of light (for example, distances less than ... microscope acts as a "nanocamera" whereas the pBNAs ... film, the effect (writing and curing) is seen ...
(Date:7/18/2014)... 2014 Emerging Nuclear Power Countries - ... , Summary , The latest report from GlobalData, Emerging ... Development Analysis to 2030 covers the emerging nuclear market ... comprehensive information on key market players and their global ... various countries across the world has also been estimated. ...
Breaking Biology Technology:Syracuse University chemist to use NSF grant to study materials chemistry, nanoscience 2A noble gas cage 2A noble gas cage 3'Nanocamera' takes pictures at distances smaller than light's own wavelength 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 2Emerging Nuclear Power Countries - Market Forecast, Key Companies and Development Analysis, Size, Share, Growth, Trend to 2030 3
... 9, 2011 PDL BioPharma, Inc. (PDL, the Company) (NASDAQ: ... offer, subject to market and other conditions, $135 million aggregate ... under the Company,s shelf registration statement filed with the U.S. ... Company also expects to grant the underwriters a 13-day overallotment ...
... La., May 9, 2011 Following a rigorous ... LLC (AE) have been recommended 1st for state ... (ITRS) component of the Board of Regents Support ... their proposal to develop breakthrough technology for harvesting ...
... Fla., May 9, 2011 Dyadic International, Inc. ... focused on the discovery, development, manufacture and sale ... industrial enzyme and biopharmaceutical industries, today announced that ... and development center in The Netherlands, will be ...
Cached Biology Technology:PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015 2PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015 3PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015 4PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015 5LSU-AgCenter and Aquatic Energy Recommended for Clean Technology Grant 2LSU-AgCenter and Aquatic Energy Recommended for Clean Technology Grant 3
(Date:7/21/2014)... hotspots in areas across Riau province on Sunday, July ... following a decline in rainfall. The number of ... what had been reported one day prior, which had ... in six regencies and municipalities, most of which were ... haze it creates could potentially spread via winds to ...
(Date:7/21/2014)... does the word "dog" have meaning? If you say ... you? , Kansas State University philosopher Elliott Wagner aims ... research, which focuses on long-standing philosophical questions about semantic ... philosophers and a mathematician are collaborating to use game ... , "If I order a cappuccino at a coffee ...
(Date:7/21/2014)... Mass. New studies being launched by neurobiologist ... will investigate how estrogens produced in the brains ... songs during a critical window during development. This ... in human children. , In a separate study, ... the idea that estrogens produced in the brain,s ...
Breaking Biology News(10 mins):Philosopher uses game theory to understand how words, actions acquire meaning 2Studying estrogens made by the brain may offer new insights in learning and memory 2Studying estrogens made by the brain may offer new insights in learning and memory 3
... date of the Neanderthal genome, scientists suggest an early ... say the authors, but do not share much else ... this week's issue of Science, also finds no evidence ... study helps to explain the evolutionary relationship between Homo ...
... molecules comprised of chains of repeating structures, are used in ... pipes to reduce flow drag to gene therapy. ... scission, and a new study by the University of Michigan ... previously thought about why polymers break when subjected to strong ...
... The Wistar Institute in Philadelphia and The Vienna Biocenter ... normal repression of the p53 protein, perhaps the single ... humans. , The new molecular pathway described in ... in the progression of many types of cancer. A ...
Cached Biology News:Genetic study of Neanderthal DNA reveals early split between humans and Neanderthals 2Genetic study of Neanderthal DNA reveals early split between humans and Neanderthals 3Scientists find new way to manipulate DNA 2Novel regulatory mechanism identified for key tumor suppressor p53 2Novel regulatory mechanism identified for key tumor suppressor p53 3
... Stabilizer is an aqueous solution that contains ... chemicals in a PBS buffer (phosphate buffered ... product contains a combination of 0.02% methylisothiazolone ... StabilCoat Plus Stabilizer provides optimum performance for ...
... ABgene's Protein Purification Plates are designed ... SDS-PAGE gels. The 96-well plates feature two ... ends of each well. The wells remain ... with buffer, during which time the protein ...
... pLivSelect is a ... for recombinant identification. Recombinant ... colony survival, eliminating the ... screening. This quick and ...
... Western Blot Signal Enhancer does for enzyme-/substrate-based blotting ... it increases the signal up to 10-fold (or ... ,The Western Blot Signal Enhancer membrane treatment ... added to your current Western blotting protocol. ...
Biology Products: